Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Sort descending Original Publication Date Journal Bone Marrow Disease
Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient Populations Advances in Therapy Paroxysmal Nocturnal Hemoglobinuria (PNH)
Complement inhibition in paroxysmal nocturnal hemoglobinuria: From biology to therapy International Journal of Laboratory Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy Haematologica Aplastic Anemia
Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy Haematologica Aplastic Anemia
Consensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusions Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes Blood Myelodysplastic Syndromes (MDS)
Consensus Recommendations for Severe Aplastic Anemia Blood Advances Aplastic Anemia
Consensus recommendations for severe aplastic anemia Blood Advances Aplastic Anemia
Consider Allogeneic Bone Marrow Transplantation for Older, Fit Patients with Aplastic Anemia Biol Blood Marrow Transplant Aplastic Anemia
Considerations for Drug Development in Myelodysplastic Syndromes Clinical Cancer Research Myelodysplastic Syndromes (MDS)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.